Editorial · 30 Nov 2024
Conference abstractPublished 18 Dec 2017
Prognostic relevance of claudins 4 and 7 in invasive breast carcinoma subtypes
Federal University of SÃ?£o Paulo, Brazil
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aims: Recently, a new molecular subtype denominated âÂ?Â?claudin-lowâÂ? (CL) was described in breast cancer and correlated to worse prognosis and to CD44+/CD24- stem cell profile. Among 19 known claudin proteins, isotypes 4 (CL4) and 7 (CL7) are the most common in the breast biology. Our aim was to verify differences in CL4 and CL7 immunoexpression between Luminal A, HER-2, and triple-negative breast cancer phenotypes; and their association to CD44/24 status and tumor prognosis. Methods: Estrogen and progesterone receptor status (ER/PR), HER-2, CL4 and CL7 expression and CD44/24 profiles were evaluated in 803 invasive ductal breast carcinomas arranged into four tissue microarrays (TMA) and results were correlated with prognosis and important clinical data. Results: 503 (62.6%) cases were positive for CL4 and 369 (46.0%) cases for CL7. The majority (199/283, 70.3%) of CL4 negative cases were clustered in the luminal A subtype whereas 63 (22.3%) showed triple-negative profile and the remaining 21 cases (7.4%) exhibited positive HER-2 expression (p<0.001). Claudin 7 negative samples (44.2%) tended to follow the same pattern. CL4 positive expression was significantly associated to HER-2 expression, presence of lymph nodes and increased tumor grades and inversely correlated to ER and PR expression. However, there was no association between CL7 expression and any of these features. Both CL4 and CL7 did not show correlation to the stem cell markers (CD44+/CD24-) or worse prognosis (survival and disease-free interval). Conclusions: Claudins 4 and 7 individual status did not provide additional prognostic information within breast cancer subtypes.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Breast Cancer: Current Research.
Editorial · 30 Nov 2024
Reconstructive Surgery Advancements Techniques and Impact on Patient Quality of Life
Editorial · 30 Nov 2024
Immunotherapy A Revolution in Cancer Treatment and Beyond
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBreast Cancer: Current Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Angela Flavia Logullo Waitzberg”